Purchase Order 75F40126P00027
Award Date 7/30/26
Potential Completion Date 1/31/30
Potential Value $4M
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
8(a) Sole Source
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Hyattsville, MD, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Food and Drug Administration has awarded a direct 8(a) sole source contract to Ivyhill-Zai, LLC, a minority-owned, small disadvantaged business and women-owned small business joint venture based in Hyattsville, Maryland, for data management support services related to FDA Industry Systems and Food Facility Registration. The award consists of two purchase orders with firm fixed-price structures: one for 10 months and one for 12 months, with a combined ceiling value of $938,794.91. Work will...
- <p>The Food and Drug Administration awarded a purchase order to Ivyhill-Zai, LLC, an 8(a) joint venture small business, for $4,488,923.62 on July 31, 2025, for records management operational support under an 8(a) sole source set-aside. The one-year base contract includes three option years, with an ultimate completion date of July 31, 2029. Work is performed at the Office of Enterprise Management Services in North Bethesda, Maryland. The contract is firm fixed price.</p>
- The Food and Drug Administration (FDA) awarded a 12-month, firm fixed-price contract valued at $859,066.90 to Ivyhill-Zai, LLC on September 4, 2025, under the 8(a) Sole Source set-aside program. The contract, structured as a purchase order, supports the FDA's Human Foods Program through record management services for the Human Foods Product Complaint System (HFCS). Ivyhill-Zai, LLC, a minority-owned and small disadvantaged business joint venture with SBA 8(a) certification, will perform the work...
- The Food and Drug Administration awarded a $5.4 million definitive contract to Ivyhill-Zai, LLC for Center for Drug Evaluation and Research and Office of Bioequivalence and International Activities document room operations on December 5, 2025, under an 8(a) sole source set-aside. The contract includes a five-week extension and carries a firm fixed-price structure. Ultimate completion is July 13, 2026. Place of performance is Hyattsville, MD. Ivyhill-Zai is an SBA-certified 8(a) joint venture,...
- The U.S. Food and Drug Administration (FDA) awarded a direct 8(a) sole source, firm fixed price contract to Ivyhill-Zai, LLC for the Petition Optical Workflow Exchange and Retrieval (POWER) system for the FDA's Human Foods Program. The 12-month base period contract has four additional 12-month option periods, with a total potential value of $4,343,091.68. Ivyhill-Zai, LLC is a minority-owned, small disadvantaged business and joint venture woman-owned small business located in Hyattsville,...
- The Food and Drug Administration issued a delivery order to Vets Synergetic Group LLC, an SBA 8(a) Joint Venture and minority-owned small disadvantaged business, on August 30, 2026, for Quality Management Information System (QMIS) administration under a competitive 8(a) set-aside. The order carries a ceiling value of $391,926.40 with ultimate completion on August 29, 2027. Place of performance is Leesburg, VA. The work supports FDA's quality management information system administration as part...
- The Food and Drug Administration issued a $2.97 million delivery order to Vets Synergetic Group LLC, an SBA-certified 8(a) joint venture, on August 19, 2025, for development of methodologies for detection of foodborne pathogens in produce, under a competitive 8(a) set-aside. This order is issued under the FDA Scientific Support IDIQ, a single-award indefinite delivery contract valued at $99.88 million and awarded to Vets Synergetic Group LLC on June 4, 2024, which provides a platform for...
- The Food and Drug Administration issued a delivery order to Immersive Concepts LLC, an 8(a) certified, HUBZone-designated, minority-owned small business, on August 3, 2022, with a ceiling value of $470,322.27 and ultimate completion date of August 4, 2024. The order was issued under the FDA Logistics Systems IDIQ, a $4.5 million indefinite-delivery contract that expires July 2029. Performance took place in Silver Spring, MD. The work covered headquarters and field mail meter equipment...
- <p>The Food and Drug Administration issued a delivery order to Advancement Strategy LLC, an 8(a) certified small disadvantaged business, on July 17, 2024, with a ceiling value of $5,261.48 under the 8(a) Sole Source set-aside for 508 compliance services.</p> <p>Place of performance is Columbia, MD. The order's ultimate completion date is September 30, 2025. This modification de-obligates funds and closes out the order under firm fixed price terms.</p>
- The Food and Drug Administration issued a delivery order to Avyon-Stafford, LLC, a minority-owned small business, on August 28, 2023, under a Total Small Business set-aside. The order has a ceiling value of $3,121,015.40 and is priced on a labor-hour basis to provide junior acquisition support specialist and administrative assistant services to the FDA's Office of Acquisitions and Grants Services. Place of performance is Rockville, Maryland. The order extends through September 29, 2028. Work...
The Food and Drug Administration issued a purchase order to Ivyhill-Zai, LLC, an 8(a) joint venture small business, for $4,020,560.36 under an 8(a) sole source set-aside, awarded July 30, 2026, with performance through January 31, 2030. The order supports data management services for the FDA's Human Food Program, including FDA Industry Systems and Food Facility Registration system operations. Performance occurs in Hyattsville, Maryland. The contract is firm fixed price.
Generated 8/20/26, 11:11 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1m | 7/22/26 |